Modern Treatment for Arterial Disease and Prevention of DVT.
Advanced Smart Compression System for VTE Prevention
The Veinoflow SCD LBTK-M-I 5001 is an advanced smart compression system designed to aid in the prevention of Venous Thromboembolism (VTE), including Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). This system provides compression therapy for the leg, calf, foot, or both, offering foot-only, leg-only, or combined foot and leg/calf compression to enhance blood circulation and reduce the risk of clot formation.
Venous thromboembolism (VTE) is a condition in which a blood clot forms most often in the deep veins of the leg, groin or arm (known as deep vein thrombosis, DVT) and travels in the circulation, lodging in the lungs (known as pulmonary embolism, PE). Together, DVT and PE are known as VTE - a dangerous, potentially deadly medical condition.
The acceleration of blood flow and the frequency of compression are the correct criteria for judging the VTE mechanical prophylaxis efficacy,
not its mere garment size!
Modern therapy concepts for arterial disease is the key to the successful treatment of related diseases such as chronic wounds and ulcers.
Faster and long-term healing of persistent ulcers.
Significant enhancement of the arterial blood supply.
Active support of the venous function with chronic venous diseases.
Our lungs are constantly producing mucus. It is our natural way to keep the lungs clear of infection. In healthy lungs, patients swallow the mucus naturally. When a person is no longer able to effectively clear mucus from their lungs on their own, airway clearance therapy becomes increasingly important to help prevent infection and inflammation.
Patient:
Male, 68 years´old
Peripheral Atherosclerotic Obliterans Disease
With a history of 13 years peripheral atherosclerotic obliterans with severe intermittent claudication of the lower left limb with local cold, numbness and rest pain for half a year. He was diagnosed with left atherosclerotic occlusion.
He was treated with the A-V Foot Pump and conventional oral medication. After half a month of treatment, the intermittent claudication distance was increased from 78 meters to 115 meters, 183 meters in the 3rd month and 191.5 meters in the 4th and 5th months (increment 146%) with the popliteal artery blood flow increase of 36% indicating an improved collateral circulation.